Literature DB >> 22700488

Subacute motor axonal neuropathy associated with the IgG anti-GalNAc-GD1a antibody.

Hirofumi Goto1, Takayasu Fukudome, Susumu Kusunoki, Hidenori Matsuo.   

Abstract

A 14-year-old boy developed a distinct asymmetrical muscle atrophy and weakness with no sensory disturbance in the lower extremities after enteritis. He had an elevated titre of the IgG antibody against GalNAc-GD1a, but none of the others. A nerve conduction study revealed motor axonopathy. Intravenous immunoglobulin therapy improved the status gradually, with low titres of IgG anti-GalNAc-GD1a.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22700488      PMCID： PMC3070378          DOI： 10.1136/bcr.11.2010.3507

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  14 in total

1.  Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.

Authors:  K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa
Journal:  Brain       Date:  2000-01       Impact factor: 13.501

2.  [A case of acute multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis].

Authors:  K Sugie; K Murata; K Ikoma; A Suzumura; T Takayanagi
Journal:  Rinsho Shinkeigaku       Date:  1998-01

3.  [A case of chronic inflammatory demyelinating neuropathy associated with antibodies to gangliosides GM1 and GalNAc-GD1a].

Authors:  M Tsukaguchi; A Yamada; K Deguchi; H Takeuchi; N Yuki
Journal:  Rinsho Shinkeigaku       Date:  1997-03

4.  Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.

Authors:  Q Hao; T Saida; H Yoshino; S Kuroki; M Nukina; K Saida
Journal:  Ann Neurol       Date:  1999-06       Impact factor: 10.422

5.  Delayed motor and sensory neuropathy in a patient with brainstem encephalitis.

Authors:  Hiro Chikakiyo; Makoto Kunishige; Hiide Yoshino; Atsuko Asano; Yuka Sumitomo; Itsuro Endo; Toshio Matsumoto; Takao Mitsui
Journal:  J Neurol Sci       Date:  2005-07-15       Impact factor: 3.181

6.  Chronic motor axonal neuropathy associated with antibodies monospecific for N-acetylgalactosaminyl GD1a.

Authors:  R Kaji; S Kusunoki; K Mizutani; N Oka; Y Kojima; N Kohara; J Kimura
Journal:  Muscle Nerve       Date:  2000-05       Impact factor: 3.217

7.  IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release.

Authors:  N Ortiz; R Rosa; E Gallardo; I Illa; J Tomas; J Aubry; M Sabater; M Santafé
Journal:  J Neuroimmunol       Date:  2001-09-03       Impact factor: 3.478

8.  Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody.

Authors:  S Kuwabara; K Ogawara; M Koga; M Mori; T Hattori; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

9.  N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome.

Authors:  S Kusunoki; A Chiba; K Kon; S Ando; K Arisawa; A Tate; I Kanazawa
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

10.  Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.

Authors:  Glenn Lopate; Rati Choksi; Alan Pestronk
Journal:  Muscle Nerve       Date:  2002-06       Impact factor: 3.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.